• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习建立三个神经酰胺代谢基因特征,以描绘胃癌患者的免疫图谱和预后。

Machine learning to establish three sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with gastric cancer.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, 315020, Ningbo, China.

出版信息

BMC Genomics. 2024 Mar 28;25(1):319. doi: 10.1186/s12864-024-10243-z.

DOI:10.1186/s12864-024-10243-z
PMID:38549047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10976768/
Abstract

BACKGROUND

Gastric cancer (GC) is one of the most common malignant tumors worldwide. Nevertheless, GC still lacks effective diagnosed and monitoring method and treating targets. This study used multi omics data to explore novel biomarkers and immune therapy targets around sphingolipids metabolism genes (SMGs).

METHOD

LASSO regression analysis was performed to filter prognostic and differently expression SMGs among TCGA and GTEx data. Risk score model and Kaplan-Meier were built to validate the prognostic SMG signature and prognostic nomogram was further constructed. The biological functions of SMG signature were annotated via multi omics. The heterogeneity landscape of immune microenvironment in GC was explored. qRT-PCR was performed to validate the expression level of SMG signature. Competing endogenous RNA regulatory network was established to explore the molecular regulatory mechanisms.

RESULT

3-SMGs prognostic signature (GLA, LAMC1, TRAF2) and related nomogram were constructed combing several clinical characterizes. The expression difference and diagnostic value were validated by PCR data. Multi omics data reveals 3-SMG signature affects cell cycle and death via several signaling pathways to regulate GC progression. Overexpression of 3-SMG signature influenced various immune cell infiltration in GC microenvironment. RBP-SMGs-miRNA-mRNAs/lncRNAs regulatory network was built to annotate regulatory system.

CONCLUSION

Upregulated 3-SMGs signature are excellent predictive diagnosed and prognostic biomarkers, providing a new perspective for future GC immunotherapy.

摘要

背景

胃癌(GC)是全球最常见的恶性肿瘤之一。然而,GC 仍然缺乏有效的诊断和监测方法以及治疗靶点。本研究使用多组学数据来探索围绕神经酰胺代谢基因(SMGs)的新型生物标志物和免疫治疗靶点。

方法

使用 LASSO 回归分析从 TCGA 和 GTEx 数据中筛选预后和差异表达的 SMGs。构建风险评分模型和 Kaplan-Meier 以验证预后 SMG 特征,并进一步构建预后列线图。通过多组学注释 SMG 特征的生物学功能。探索 GC 中免疫微环境的异质性景观。通过 qRT-PCR 验证 SMG 特征的表达水平。建立竞争性内源性 RNA 调控网络,探索分子调控机制。

结果

构建了结合几个临床特征的 3-SMGs 预后特征(GLA、LAMC1、TRAF2)和相关列线图。通过 PCR 数据验证了表达差异和诊断价值。多组学数据表明,3-SMG 特征通过几种信号通路影响细胞周期和死亡,从而调节 GC 的进展。3-SMG 特征的过表达影响 GC 微环境中各种免疫细胞的浸润。构建 RBP-SMGs-miRNA-mRNAs/lncRNAs 调控网络以注释调控系统。

结论

上调的 3-SMGs 特征是优秀的预测诊断和预后生物标志物,为未来的 GC 免疫治疗提供了新视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/c0fb797e2ab0/12864_2024_10243_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/342a9dc72128/12864_2024_10243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/05f44d0c5a69/12864_2024_10243_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/fcd78f73b6fc/12864_2024_10243_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/62da4b65b9ff/12864_2024_10243_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/8c3aea9cc9df/12864_2024_10243_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/4c4606461075/12864_2024_10243_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/c765097b816f/12864_2024_10243_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/c0fb797e2ab0/12864_2024_10243_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/342a9dc72128/12864_2024_10243_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/05f44d0c5a69/12864_2024_10243_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/fcd78f73b6fc/12864_2024_10243_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/62da4b65b9ff/12864_2024_10243_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/8c3aea9cc9df/12864_2024_10243_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/4c4606461075/12864_2024_10243_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/c765097b816f/12864_2024_10243_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e69/10976768/c0fb797e2ab0/12864_2024_10243_Fig8_HTML.jpg

相似文献

1
Machine learning to establish three sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with gastric cancer.机器学习建立三个神经酰胺代谢基因特征,以描绘胃癌患者的免疫图谱和预后。
BMC Genomics. 2024 Mar 28;25(1):319. doi: 10.1186/s12864-024-10243-z.
2
Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma.机器学习构建神经鞘脂代谢基因特征,以描绘眼葡萄膜黑色素瘤患者的免疫图谱和预后。
Front Endocrinol (Lausanne). 2022 Dec 8;13:1056310. doi: 10.3389/fendo.2022.1056310. eCollection 2022.
3
A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.基于检查淋巴结数量相关特征的列线图模型预测胃癌的预后并指导临床治疗。
Front Immunol. 2022 Nov 2;13:947802. doi: 10.3389/fimmu.2022.947802. eCollection 2022.
4
A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.一种新型铜诱导细胞死亡相关 lncRNA 预后标志物与胃癌免疫浸润和临床价值相关。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10543-10559. doi: 10.1007/s00432-023-04916-7. Epub 2023 Jun 8.
5
Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.胃癌中 m6A 相关 lncRNAs 的肿瘤免疫微环境综合分析与预后评估。
BMC Cancer. 2022 Mar 24;22(1):316. doi: 10.1186/s12885-022-09377-8.
6
Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.基于肿瘤微环境相关基因集的胃癌预后特征及相关治疗靶点的鉴定。
Theranostics. 2020 Jul 9;10(19):8633-8647. doi: 10.7150/thno.47938. eCollection 2020.
7
A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients.基于 ceRNA 和免疫状态的新型标志物可预测胃癌患者的预后风险和药物敏感性。
Front Immunol. 2022 Nov 22;13:951135. doi: 10.3389/fimmu.2022.951135. eCollection 2022.
8
Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing.通过单细胞和批量 RNA 测序的综合分析,发现了一种新型的脂质代谢相关基因特征,用于预测胃癌的结局和肿瘤免疫微环境。
Lipids Health Dis. 2023 Dec 2;22(1):212. doi: 10.1186/s12944-023-01977-y.
9
Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.通过单细胞和批量 RNA 测序数据的综合分析,鉴定和验证上皮-间充质转化相关细胞的生物标志物,以评估原发性胃癌的预后和免疫微环境。
Math Biosci Eng. 2023 Jun 16;20(8):13798-13823. doi: 10.3934/mbe.2023614.
10
Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.整合单细胞 RNA 测序分析揭示了间充质干细胞相关特征,可用于评估胃癌的预后和药物敏感性。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11829-11847. doi: 10.1007/s00432-023-05058-6. Epub 2023 Jul 6.

引用本文的文献

1
Regulation of sphingolipid metabolism in the immune microenvironment of gastric cancer: current insights and future directions.胃癌免疫微环境中鞘脂代谢的调控:当前见解与未来方向
Front Oncol. 2025 Jul 31;15:1604227. doi: 10.3389/fonc.2025.1604227. eCollection 2025.
2
Associations between blood metabolite levels and gastrointestinal cancer risk: A preliminary untargeted metabolomics study.血液代谢物水平与胃肠道癌症风险之间的关联:一项初步的非靶向代谢组学研究。
World J Gastrointest Oncol. 2025 Jul 15;17(7):104860. doi: 10.4251/wjgo.v17.i7.104860.
3
Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression.

本文引用的文献

1
Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer.二硫键化相关基因在胃癌中的临床意义及功能分析
J Cancer. 2024 Jan 1;15(4):1053-1066. doi: 10.7150/jca.91796. eCollection 2024.
2
TarBase-v9.0 extends experimentally supported miRNA-gene interactions to cell-types and virally encoded miRNAs.TarBase-v9.0 将实验支持的 miRNA-基因相互作用扩展到细胞类型和病毒编码的 miRNA。
Nucleic Acids Res. 2024 Jan 5;52(D1):D304-D310. doi: 10.1093/nar/gkad1071.
3
Identification of basement membrane markers in diabetic kidney disease and immune infiltration by using bioinformatics analysis and experimental verification.
肿瘤浸润淋巴细胞和三级淋巴结构在胃癌进展中的作用与功能。
Front Immunol. 2025 May 29;16:1595070. doi: 10.3389/fimmu.2025.1595070. eCollection 2025.
4
Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets.胰腺癌中的免疫抑制性肿瘤微环境:机制与治疗靶点
Front Immunol. 2025 May 15;16:1582305. doi: 10.3389/fimmu.2025.1582305. eCollection 2025.
5
Comprehensive pan-cancer analysis indicates key gene of p53-independent apoptosis is a novel biomarker for clinical application and chemotherapy in colorectal cancer.全面的泛癌分析表明,p53非依赖性凋亡的关键基因是结直肠癌临床应用和化疗的一种新型生物标志物。
Front Immunol. 2025 Mar 27;16:1571137. doi: 10.3389/fimmu.2025.1571137. eCollection 2025.
6
Single-cell analysis unveils cell subtypes of acral melanoma cells at the early and late differentiation stages.单细胞分析揭示了肢端黑色素瘤细胞在早期和晚期分化阶段的细胞亚型。
J Cancer. 2025 Jan 1;16(3):898-916. doi: 10.7150/jca.102045. eCollection 2025.
7
Integrated bulk and single-cell profiling characterize sphingolipid metabolism in pancreatic cancer.整合 bulk 和单细胞分析描绘了胰腺癌中的神经酰胺代谢。
BMC Cancer. 2024 Nov 1;24(1):1347. doi: 10.1186/s12885-024-13114-8.
利用生物信息学分析和实验验证鉴定糖尿病肾病的基底膜标志物和免疫浸润。
IET Syst Biol. 2023 Dec;17(6):316-326. doi: 10.1049/syb2.12078. Epub 2023 Sep 30.
4
Impact of Structural GLA Protein Changes on Peripheral GLA Activity and Substrate Accumulation in Fabry Disease Patients.结构GLA蛋白变化对法布里病患者外周GLA活性和底物积累的影响。
Endocr Metab Immune Disord Drug Targets. 2023 Sep 14. doi: 10.2174/1871530323666230914114414.
5
Predictive biomarkers and new developments of immunotherapy in gastric cancer: a 2023 update.胃癌免疫治疗的预测性生物标志物及新进展:2023年更新
Am J Cancer Res. 2023 Jul 15;13(7):3169-3184. eCollection 2023.
6
Immune escape and resistance to immunotherapy in mismatch repair deficient tumors.错配修复缺陷肿瘤中的免疫逃逸和免疫治疗耐药性。
Front Immunol. 2023 Jul 10;14:1210164. doi: 10.3389/fimmu.2023.1210164. eCollection 2023.
7
TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma.TRAF2 通过抑制透明细胞肾细胞癌中的自噬作用促进 M2 极化的肿瘤相关巨噬细胞浸润、血管生成和癌症进展。
J Exp Clin Cancer Res. 2023 Jul 6;42(1):159. doi: 10.1186/s13046-023-02742-w.
8
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.NUDT21 通过差异可变多聚腺苷酸化 LAMC1 改变神经胶质瘤迁移。
J Neurooncol. 2023 Jul;163(3):623-634. doi: 10.1007/s11060-023-04370-y. Epub 2023 Jun 30.
9
Immunology and immunotherapy in gastric cancer.胃癌的免疫学和免疫治疗。
Clin Exp Med. 2023 Nov;23(7):3189-3204. doi: 10.1007/s10238-023-01104-2. Epub 2023 Jun 15.
10
The tumor suppressor role and ceRNA network of miR-1294 in cancer.miR-1294 在癌症中的肿瘤抑制作用和 ceRNA 网络。
Oncol Res. 2023 Mar 1;31(1):1-12. doi: 10.32604/or.2022.027359. eCollection 2023.